CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,197,943 | +21.4% | 957,951 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $5,104,453 | +78.2% | 824,629 | +10.9% | 0.00% | – |
| Q1 2023 | $2,864,043 | +193.2% | 743,907 | +136.1% | 0.00% | – |
| Q4 2022 | $976,919 | +1358.1% | 315,135 | +1810.6% | 0.00% | – |
| Q3 2022 | $67,000 | -65.8% | 16,494 | -59.0% | 0.00% | – |
| Q2 2022 | $196,000 | +1.0% | 40,264 | +86.3% | 0.00% | – |
| Q1 2022 | $194,000 | +22.8% | 21,612 | +53.4% | 0.00% | – |
| Q4 2021 | $158,000 | +23.4% | 14,085 | +84.6% | 0.00% | – |
| Q3 2021 | $128,000 | – | 7,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $89,357,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $179,070,000 | 48.51% |
| Vida Ventures Advisors, LLC | 3,931,818 | $35,268,000 | 20.51% |
| OUP Management Co., LLC | 2,937,615 | $26,350,000 | 20.06% |
| Samsara BioCapital, LLC | 1,884,096 | $16,900,000 | 4.26% |
| Kynam Capital Management, LP | 669,100 | $6,002,000 | 1.95% |
| Cormorant Asset Management, LP | 2,489,894 | $22,334,000 | 1.72% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $86,846,000 | 0.79% |
| RA Capital Management | 3,577,094 | $32,087,000 | 0.70% |
| BVF INC/IL | 1,755,545 | $15,747,000 | 0.63% |